Table 3.

Association of TNF‐α polymorphism with biochemical and anthrometric characteristics of subjects

Groups	Genotype	Height	Weight	BMI	WC	HC	TC	TG	HDL	LDL	FBG	SBP	DBP	hsCRP
Control	GG	161±9	69±12	25±4	91±12	99±7	192±37	135.3±70.6	41±8	115±38	84±16	121±16	74±10	1.4 (0.8‐2.3)
	GA	159±14	71±13	26±4	92±13	102±10	193±36	133.5±76.2	41±8	120±32	92±38	125±20	77±9	1.7 (1.0‐5.0)
	AA	159±9	71±9	26±2	94±10	103±7	203±41	154.2±108.2	39±8	121±43	85±15	119±17	77±12	3.5 (1.3‐10.4)
	P	.4	.2	.8	.4	.02	.3	.7	.2	.5	.1	.2	.1	<.001
CAD patients with <50% obstruction	GG	157±16	68±13	27±5	93±11	99±9	171±47	133.4±58.9	43±11	100±38	116±49	134±23	81±11	3.9 (1.6‐4.9)
	GA	159±9	66±14	25±5	93±13	100±9	173±44	148.6±99.9	43±10	99±36	110±38	142±25	85±12	3.9 (1.5‐4.8)
	AA	156±21	69±14	27±5	94±11	100±9	160±38	126.6±56.9	42±9	97±25	124±69	127±24	81±12	4.8 (3.8‐9.1)
	P	.7	.4	.3	.5	.3	.4	.5	.9	.9	.5	.01	.09	.023
CAD patients with ≥50% obstruction	GG	160±20	70±14	27±5	93±11	92±9	172±44	151.9±74.1	40±9	101±36	127±60	140±24	84±10	5.3 (1.7‐6.4)
	GA	158±20	70±12	27±5	93±13	100±10	165±43	144.6±75.1	42±19	95±31	136±64	134±25	81±10	5.8 (2.3‐6.5)
	AA	160±11	69±13	27±5	93±12	100±9	171±55	171.7±113.2	39±10	94±29	134±53	143±28	80±13	5.4 (2.3‐6.8)
	P	.7	.8	.8	.9	.4	.3	.3	.2	.1	.3	.03	.002	.125

BMI, body mass index; WC, Waist circumference, HC, Hip circumference, TC, total cholesterol; TG, triglycerides; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Values are expressed as mean±SD or median and interquartile range. Comparisons were made by the χ2 test (for categorical data), one‐way ANOVA and Kruskal‐Wallis test (for numerical data). Also, the post hoc and Mann‐whitney test were used for comparison between groups.

P‐value <.05 was considered significant.